Overview

Outcome of Omega 3 FA and Punctal Plugs on Ocular Surface Disease

Status:
Completed
Trial end date:
2019-11-20
Target enrollment:
Participant gender:
Summary
Ocular surface disease is a common adverse effect of systemic isotretinoin therapy. The investigators consider that punctal plugs and Omega 3 is a good line for treatment of ocular surface disease associated with systemic isotretinoin therapy
Phase:
Phase 4
Details
Lead Sponsor:
Benha University
Treatments:
Hyaluronic Acid
Ophthalmic Solutions